Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany. frank.buttgereit@charite.de
BACKGROUND: Circadian rhythms are changed in patients with rheumatoid arthritis. A new modified-release delivery system has been developed which adapts the release of the administered glucocorticoid to the circadian rhythms of endogenous cortisol and disease symptoms to improve the benefit-risk ratio of glucocorticoid therapy in rheumatoid arthritis. We aimed to assess the efficacy and safety of a new modified-release prednisone tablet compared with immediate-release prednisone in patients with this disease. METHODS: In a 12-week, multicentre, randomised, double-blind trial, 288 patients with active rheumatoid arthritis were randomly assigned to either a modified-release prednisone tablet (n=144) or to an immediate-release prednisone tablet (n=144). The modified-release tablet was taken at bedtime and prednisone was released with a delay of 4 h after ingestion. This treatment was compared with morning administration of immediate-release prednisone as an active comparator. The primary outcome measure was duration of morning stiffness of the joints. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00146640. FINDINGS: The mean relative change in duration of morning stiffness of the joints from baseline to end of treatment was significantly higher with modified-release prednisone than with immediate-release prednisone (-22.7%vs -0.4%; difference=22.4% [95% CI 0.49-44.30]; p=0.045). Patients in the prednisone modified-release group achieved a mean reduction of 44.0 (SD 136.6) min compared with baseline. The absolute difference between the treatment groups was 29.2 min (95% CI -2.59 to 61.9) in favour of modified-release prednisone (p=0.072). The safety profile did not differ between treatments. INTERPRETATION: Modified-release prednisone is well tolerated, convenient to administer, and produces a clinically relevant reduction of morning stiffness of the joints in addition to all known therapeutic effects of immediate-release prednisone.
I'm interested in this and am wondering if anyone else taking pred has any further info or comment on this new med.
K.Circadian rhythms are important in determining the sleeping and feeding patterns of all animals, including human beings. There are clear patterns of core body temperature, brain wave activity, hormone production, cell regeneration and other biological activities linked to this daily cycle. In addition, photoperiodism, the physiological reaction of organisms to the length of day or night, is vital to both plants and animals, and the circadian system plays a role in the measurement and interpretation of daylength.
Boney,
I'm totally with ya on the 24/7 pred reliance. Like you, this is the only Rx drug that I take for my inflammatory RA. I take the pred in the morning, around 5-6AM, with my other, non-RA related meds. I have insomnia, so the idea of taking the pred at 2AM instead isn't a big issue for me, in terms of having to wake up to take it, so I took the pred at 2AM today. When I awakened, I didn't feel quite as stiff as I normally do. I'm going to continue to take the pred at 2AM for a couple weeks and see if it makes a difference in duration of morning stiffness for me. However, by mid-day, just about every flippin' joint, and connective tissue in my body is stiff and aching like hell again anyway. Our weather here has been cold, wet and nasty the last few days and my RA seems to flare more when the barometric pressure fluctuates.
I hate pred. *shudder* I can't take it, but I know a lot of our members depend on it for much needed relief. I have to wonder though - I know Pred makes people eat more often, would time-released Pred result in 24/7 munchies or would it just level off at some point? Would you get used to the feeling and start to eat normally again? Stupid questions probably. I just wonder.
hi katalina you are a early riser ..i do the same as you and take all my meds in